CMON Limited will convene its Annual General Meeting (AGM) on 30 June 2026 at 11:00 a.m. (Singapore time) at Blk 163 Bukit Merah Central #03-3581, Singapore 150163. Shareholders will vote on several ordinary resolutions that shape the company’s capital management and governance for the coming year.
Key items for shareholder approval include:
• Financial Statements: Receipt and adoption of the audited consolidated financial statements for the year ended 31 December 2025 together with the directors’ and auditor’s reports.
• Board Composition: Re-election of Executive Directors Mr Ng Chern Ann and Mr David Doust, and Independent Non-Executive Director Mr Choy Man.
• Directors’ and Auditor’s Remuneration: Authorisation for the board to fix directors’ remuneration and re-appointment of ZHONGHUI ANDA CPA Limited as auditor, with its fee to be set by the board.
• Share Issuance Mandate: A general mandate permitting the board to allot, issue, and deal in additional shares or convertible securities up to 20 % of the issued share capital (excluding treasury shares) as at the date of the AGM. The mandate also allows the board to grant related offers or options during the mandate period.
• Share Buyback Mandate: A separate mandate authorising the company to repurchase up to 10 % of its issued shares (excluding treasury shares) on the Hong Kong Stock Exchange or other recognised bourses, subject to applicable regulations.
• Mandate Extension: Conditional on the above mandates passing, the aggregate number of shares repurchased under the buyback mandate may be added to the 20 % issuance limit, effectively extending the potential issuance capacity by a further 10 %.
Shareholders registered by 30 June 2026 are entitled to attend and vote. The register of members will be closed from 25 June to 30 June 2026, and all share transfers must be lodged with Tricor Investor Services Limited by 4:30 p.m. on 24 June 2026 to qualify.
All resolutions will be decided by poll in accordance with Hong Kong Listing Rules. The board currently has no immediate plans to exercise the proposed issuance or repurchase mandates and will act only when deemed in the best interests of the company and its shareholders.
Comments